إعلان
إعلان

CLLS

CLLS logo

Cellectis S.A. - ADR

4.47
USD
برعاية
-0.08
-1.76%
٠٨ يناير, ١٥:٥٨ UTC -5
مغلق
exchange

بعد الإغلاق

4.47

0.00
0.00%

تقارير أرباح CLLS

النسبة الإيجابية المفاجئة

CLLS تفوق 14 من 21 آخر التقديرات.

67%

التقرير التالي

بيانات التقرير القادم
١١ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$7.70M
/
-$0.36
التغير الضمني من Q3 25 (Revenue/ EPS)
-79.29%
/
-3700.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
-49.24%
/
-550.00%

Cellectis S.A. - ADR earnings per share and revenue

On ٠٧ نوفمبر ٢٠٢٥, CLLS reported earnings of 0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.28 USD, resulting in a 103.50% surprise. Revenue reached 37.16 مليون, compared to an expected 7.11 مليون, with a 422.92% difference. The market reacted with a +11.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of -0.36 USD, with revenue projected to reach 7.70 مليون USD, implying an نقصان of -3700.00% EPS, and نقصان of -79.29% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Cellectis S.A. - ADR reported EPS of $0.01, beating estimates by 103.5%, and revenue of $37.16M, 422.92% above expectations.
The stock price moved up 11.29%, changed from $3.19 before the earnings release to $3.55 the day after.
The next earning report is scheduled for ١١ مارس ٢٠٢٦.
Based on 6 المحللين, Cellectis S.A. - ADR is expected to report EPS of -$0.36 and revenue of $7.70M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان